Search
for
Sort by
Research 181–210 of 1000+
- 448 Challenges of securing insurance approval for oral tofacitinib treatment of alopecia areata: A multi-institutional retrospective review
- 1338 Dermal Wnt/β-catenin activation tunably controls hair follicle initiation
- 1336 The de novo DNA methyltransferase DNMT3A is required for epidermal homeostasis
- Westwood Carolina Conference on Clinical Dermatology
- Hair cycle control by leptin as a new anagen inducer
- CD10 and CD34 in fetal and adult human hair follicles: dynamic changes in their immunohistochemical expression during embryogenesis and hair cycling
- Topical minoxidil in the treatment of alopecia areata.
- Functional ectodermal organ regeneration as the next generation of organ replacement therapy
- Effect of extracting process on saponin content and antioxidant activity of Gleditschia fera (Lour.) Merr dried fruit extract
- Oral cyclosporin does not arrest progression of androgenetic alopecia
- Aging and Immortality: Quasi-Programmed Senescence and Its Pharmacologic Inhibition
- The PDGF/PDGFR pathway as a drug target
- The Harmonies Played by TGF-β in Stem Cell Biology
- TGF-β family signaling in stem cells
- Drug-Induced Skin, Nail and Hair Disorders
- Targeting the Wnt pathways for therapies
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Niosomes as a propitious carrier for topical drug delivery
- Compartmentalized organization: a common and required feature of stem cell niches?
- Hair disorders in patients with cancer
- Phenotypic Diversity and Mutation Spectrum in Hypotrichosis with Juvenile Macular Dystrophy
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- An Update on Drug-Induced Pigmentation
- Niosomes as Carrier in Dermal Drug Delivery
- Drug eruptions in dermatology
- Clinical Development of Topoisomerase-Interactive Drugs
- Scalp Tourniquets for Chemotherapy-Induced Alopecia
- Conceptual Basis for Use of Chemotherapeutic Agents and Their Pharmacology
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- Cutaneous drug reactions